Labcorp Holdings EBITDA 2010-2025 | LH
Labcorp Holdings annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Labcorp Holdings EBITDA for the quarter ending June 30, 2025 was $0.565B, a 25.04% increase year-over-year.
- Labcorp Holdings EBITDA for the twelve months ending June 30, 2025 was $1.860B, a 37.87% increase year-over-year.
- Labcorp Holdings 2024 annual EBITDA was $1.73B, a 32.8% increase from 2023.
- Labcorp Holdings 2023 annual EBITDA was $1.303B, a 33.99% decline from 2022.
- Labcorp Holdings 2022 annual EBITDA was $1.974B, a 45.56% decline from 2021.
| Labcorp Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,730 |
| 2023 | $1,303 |
| 2022 | $1,974 |
| 2021 | $3,626 |
| 2020 | $3,532 |
| 2019 | $1,907 |
| 2018 | $1,878 |
| 2017 | $1,838 |
| 2016 | $1,771 |
| 2015 | $1,457 |
| 2014 | $1,152 |
| 2013 | $1,223 |
| 2012 | $1,256 |
| 2011 | $1,184 |
| 2010 | $1,188 |
| 2009 | $1,139 |
| Labcorp Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $565 |
| 2025-03-31 | $493 |
| 2024-12-31 | $385 |
| 2024-09-30 | $418 |
| 2024-06-30 | $452 |
| 2024-03-31 | $476 |
| 2023-12-31 | $8 |
| 2023-09-30 | $413 |
| 2023-06-30 | $409 |
| 2023-03-31 | $472 |
| 2022-12-31 | $76 |
| 2022-09-30 | $507 |
| 2022-06-30 | $540 |
| 2022-03-31 | $851 |
| 2021-12-31 | $540 |
| 2021-09-30 | $953 |
| 2021-06-30 | $891 |
| 2021-03-31 | $1,242 |
| 2020-12-31 | $1,478 |
| 2020-09-30 | $1,660 |
| 2020-06-30 | $442 |
| 2020-03-31 | $-48 |
| 2019-12-31 | $492 |
| 2019-09-30 | $484 |
| 2019-06-30 | $477 |
| 2019-03-31 | $454 |
| 2018-12-31 | $445 |
| 2018-09-30 | $477 |
| 2018-06-30 | $508 |
| 2018-03-31 | $448 |
| 2017-12-31 | $475 |
| 2017-09-30 | $460 |
| 2017-06-30 | $457 |
| 2017-03-31 | $446 |
| 2016-12-31 | $412 |
| 2016-09-30 | $446 |
| 2016-06-30 | $490 |
| 2016-03-31 | $422 |
| 2015-12-31 | $352 |
| 2015-09-30 | $429 |
| 2015-06-30 | $440 |
| 2015-03-31 | $236 |
| 2014-12-31 | $277 |
| 2014-09-30 | $300 |
| 2014-06-30 | $310 |
| 2014-03-31 | $265 |
| 2013-12-31 | $275 |
| 2013-09-30 | $303 |
| 2013-06-30 | $327 |
| 2013-03-31 | $318 |
| 2012-12-31 | $275 |
| 2012-09-30 | $303 |
| 2012-06-30 | $333 |
| 2012-03-31 | $345 |
| 2011-12-31 | $306 |
| 2011-09-30 | $298 |
| 2011-06-30 | $285 |
| 2011-03-31 | $295 |
| 2010-12-31 | $293 |
| 2010-09-30 | $287 |
| 2010-06-30 | $322 |
| 2010-03-31 | $286 |
| 2009-12-31 | $267 |
| 2009-09-30 | $286 |
| 2009-06-30 | $296 |
| 2009-03-31 | $291 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.210B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.791B | 27.22 |
| CVS Health (CVS) | United States | $91.231B | 11.35 |
| Elevance Health (ELV) | United States | $69.762B | 9.38 |
| Cencora (COR) | United States | $56.333B | 18.76 |
| DiDi Global (DIDIY) | China | $26.403B | 28.05 |
| Natera (NTRA) | United States | $22.377B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.898B | 0.00 |
| ICON (ICLR) | Ireland | $14.052B | 13.52 |
| Medpace Holdings (MEDP) | United States | $13.301B | 35.20 |
| CochLear (CHEOY) | Australia | $12.977B | 0.00 |
| Solventum (SOLV) | United States | $12.638B | 13.04 |
| Viatris (VTRS) | United States | $12.148B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.748B | 0.00 |
| Revvity (RVTY) | United States | $10.283B | 18.12 |
| Avantor (AVTR) | United States | $8.992B | 13.19 |
| Charles River Laboratories (CRL) | United States | $8.012B | 15.20 |
| Sonic Healthcare (SKHHY) | Australia | $7.799B | 0.00 |
| HealthEquity (HQY) | United States | $7.608B | 33.33 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.687B | 26.19 |
| BrightSpring Health Services (BTSG) | United States | $4.239B | 32.34 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.711B | 84.99 |
| Alignment Healthcare (ALHC) | United States | $3.196B | 0.00 |
| Concentras Parent (CON) | United States | $2.993B | 18.98 |
| Surgery Partners (SGRY) | United States | $2.926B | 36.81 |
| Organon (OGN) | United States | $2.392B | 2.61 |
| KindlyMD (NAKA) | United States | $2.377B | 0.00 |
| Premier (PINC) | United States | $2.161B | 20.04 |
| Progyny (PGNY) | United States | $1.979B | 41.85 |
| Ardent Health (ARDT) | United States | $1.819B | 7.02 |
| PACS (PACS) | United States | $1.807B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.564B | 26.47 |
| Pediatrix Medical (MD) | United States | $1.496B | 9.99 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Omada Health (OMDA) | $1.343B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.230B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.853B | 5.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.771B | 9.53 |
| CareDx (CDNA) | United States | $0.707B | 13.03 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.539B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Nutex Health (NUTX) | United States | $0.499B | 7.55 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.453B | 0.00 |
| SBC Medicals (SBC) | United States | $0.434B | 9.50 |
| Enhabit (EHAB) | United States | $0.406B | 26.67 |
| So-Young (SY) | China | $0.399B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.304B | 0.00 |
| Beauty Health (SKIN) | United States | $0.260B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.240B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.158B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |